Crown Plaza, Ortigas, September 10, 2019 – Finding the right connection can be the key in preventing and predicting devastating health events like a heart attack. Through its partnership with Zuellig Pharma Corporation, Amgen Philippines Inc aims to help improve awareness of cardiovascular diseases (CVD) with educational initiatives to achieve the goal of changing the way the disease is manged and prevented.
Cardiovascular disease (CVD), including heart disease and stroke, is the leading cause of death among the Filipinos. Knowledge about CVD can influence their adopting healthy lifestyle behaviors. Lack of knowledge and misconceptions about CVD risk can lead to delays in seeking treatment and increased risk for sudden death. Despite great strides in promoting public health outreach educational programs, survey findings still show that many filipinos have lack of knowledge about heart disease and prevention strategies. A number of factors in addition to weight may contribute to the risk for CVD in this subpopulation, including sedentary lifestyles; high rates of diabetes, metabolic syndrome, and other chronic conditions (eg, hypertension, hypercholesterolemia); and socioenvironmental factors .
In the Philippines, there are over 130,000 deaths related to Cardiovascular disease in 2016. CVD is a complex disease with many risk factors that affects how it develops. One such risk is dyslipidemia, which occurs when one has abnormal levels of lipids in the blood. Lipids or fats are essential in providing energy to the cells while cholesterol is vital in the production of hormones and bile acids for healthy digestion.
There are two kinds of cholesterol in the body : “Bad” cholesterol and :good” cholesterol. Elevated bad cholesterol, also known as low density lipoprotein ( LDL-C) in the blood increases a person’s risk of developing atherosclerotic plaque deposits which can block the arteries and lead to a heart attack or stroke. Lowering LDL-C also lowers a person’s chances of developimg CVD.
Simple pairwise correlations showed no significant relationship between CVD knowledge scores (number correct) and overall dietary habits score, background characteristics (age, education, acculturation, and years living in the Philippines ) or physical activity.
For example, the participants with higher CVD knowledge were more likely to “Choose foods labeled low sodium, sodium free, or no salt added.” The knowledge score was not significantly related, using multi variable linear regression, to background characteristics (age, education, acculturation level, years living in the Philippines), BMI, or physical activity.
The standard treatment for lowering LDL-C are stains, but there are cases when statins are not enough. Having access to new and innovative treatments in the management of dyslipidemia can make a difference for patients who are not able to achieve their lipid goals with statin alone.
With the patient at the heart of what we do, Amgen Philippines Inc. and Zuellig Pharma Corporation are committed to improving the lives of patients struggling with dyslipidemia by helping them and their families to take the necessary action to prevent and manage their health risks.